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This paper describes an instrumentation system for positron
emission tomography (PET). A variety of [Z-11C]labelled
aldoses, such as [1-11C]-D-glucose, andgalactose by a modification
ofthe Kiliani-Fischer methodhave beenproduced. The instrumenta-
tion is fully automatic and consists of a synthesis system and a
control system. The synthesis system has the following functions:
supplying reagents; performing reactions; purifying 11C labelled
aldose; andpreparing an injectable solution of 11C labelled aldose.
These operations are performed by the control system in a remote
control room. In a preliminary, hot experiment an injectable solution
of [1-11C]-D-glucose was obtained. In addition, the operator is
exposed to minimal radiation. The radioactivity of [1-11C]-D-
glucose was 47 MBq, and the preparation time was 49 min.
Introduction
Positron emission tomography (PET) [1] is a non-invasive
imaging technique which can obtain biofunctional infor-
mation from humans and animals using radiopharma-
ceuticals containing a positron emitter (for example 11C,
150 and 18F). There is currently great interest in the
production of radiotracers for PET. [-1-11C]labelled
aldoses are very useful radiotracers for regional cerebral
glucose metabolism [2] and tumor markers [3]. However,
there are some major synthetic problems in their prepara-
tion. 11C has a radioactive half-life of only 20"4 min and
decays with the evolution of X-rays (energy 511 keV).
Moreover, the synthetic scale has to be very small be-
cause only pico-mol order of 11C can be obtained by
14N(p, z)11C reaction using a cyclotron. To overcome
these difficulties, the preparation process has to be rapid,
reproducible and on a micro scale. So the development
of a rapid, stereoselective reaction and automation of the
process are very important and the authors have been
working on this.
The first synthesis of [ 1-11C]-D-glucose using the classical
Kiliani-Fischer method was reported by Shiue el al. [4],
and recently Schoeps et al. I-5] reported the preparation
of [1-11C]-D-glucose from [11C]-nitromethane using a
Nef reaction. In these approaches, the final product is
obtained as a mixture of [ 1-11C]-D-glucose and mannose,
and the ratio of D-glucose to mannose was reported to be
from 0"25 to 0"5. More recently, Carmen et al. [6-1 have
improved the ratio ofD-glucose to mannose by the reaction
of D-arabinose with NH411CN in pH 8" borate buffer--
the ratio was improved to 1"80 ___
0"57 in favour of
D-glucose. Using these synthetic methods, several groups
[-7, 8] have developed remote or automated instruments
for preparing [1-11C]_D_glucose. However, the majority
of these instruments were not fully automatic and were
not very flexible. This paper describes a new method for
preparing optical isomers by changing the reaction
conditions and a new instrument set up which is fully
automatic and can synthesize other [1-11C]labelled
aldoses.
Method
Development of a rapid synthetic method
Micro-scale synthetic study ofaldoses was performed using
a mock-up apparatus and cold experiments. The focus
was on a modification of the Kiliani-Fischer method.
Cyanohydrin formation with sodium cyanide and 2,3:4,5-
di-O-isopropylidene-D-arabinose (1) I-9] was investigated,
and the optimum reaction conditions for preparing
3,4:5,6-di-O-isopropylidene-D-glucononitrile (_2) [10] or
mannononitrile (3_) [10] by HPLC analysis were deter-
mined. Each aldononitrile was then converted to D-glucose
or mannose by reductive hydrolysis with Raney nickel.
In a similar manner, rapid synthetic methods for other
aldoses were also investigated.
Construction of automated instrumentation
The automated instrument was built for the synthetic
method. To minimize the operator’s exposure to radiation,
the hardware was designed to produce an injectable
solution through a remote control. The apparatus was
designed for laboratory use and for ease of improvement
of the hardware and software. The software was pro-
grammed with Hyakuninriki (Asahi Electronics Co. Ltd,
Japan) which operates under MS-DOS.
Hot experiment
After examining the synthesis of the aldoses in the cold
test, an attempt was made to produce an injectable
solution of [-1-11C]-D-glucose from HllCN [11] gas,
which is prepared with a cyclotron and a HllCN gas
generator--see figure 1o The production of 11C was
accomplished by the nuclear reaction of accelerated
protons with high pressured 14N2 gas. This reaction was
performed with a cyclotron and a target chamber. The
pico mole quantities of 11C undergo rapid oxidation to
11CO2 in the target chamber. The 11CO2 gas was then
transferred to the H11CN gas generator and converted to
0142-0453/94 $10.00 (C) 1994 Taylor & V is Ltd. 195S. Nishimura et al. Automated synthesis of radiopharmaceuticals for PET
Cyclotron Room
Cyclotron
accelerated proton
Target Chamber
Radiation Shielded Room
Apparatus for
[].11C]Aldoses
[1.1 ! C]Aldose
PET Camera Room
PET
Camera
11CO2
H11CN
HPLC
RIDC
Remote Controlling Room
Figure 1. Diagram of the production systemfor [1-11C]labelled aldoses. PC1 personal computer (PC-9801RA, NEC) for controlling
a cyclotron (HM-18, SHI), PC2 personal computer (PC-9801FA, NEC)for controlling Eq. 1, PC3 personal computer (PC-9801BX,
NEC)for controlling Eq. 2, PC4 personal computer (PC-9821Ap, NEC)for controlling the apparatus, DP data processor (C-R4AX,
Shimadzu), Eq. 1 11C02 gas concentration equipment (AMCT 01, NKK Corp.), Eq. 2 HllCN gas generator (AMMC 01,
NKK Corp.), RIDC radioisotope dose calibrator, WS work station (SPARK station 10, SUN microsystems).
H11CN gas as shown below:
H2
02 Ru SiO2 14N/,,, o0,1-, I1 lc
=_ 1lco2 = 11CH4
NH3, Pt
=- H11CN
Using the H11CN gas as the starting material, the
automated synthesis of [- 1-11C-]_D_glucose was attempted.
These operations were performed with four personal
computers, and could be monitored with CCD video
cameras in the remote controlling room. The product was
analysed with a radioisotope dose calibrator and a HPLC
system by remote monitoring and controlling.
Results and discussion
Chemistry
In order to investigate the possibility of selectively
synthesizing either isomer by changing reaction conditions,
reaction rate and the steroselectivity of cyanohydrin
formation was examined. As a typical example, the
reaction of compound 1 with one equivalent of sodium
cyanide in a mixture of organic solvent and alkali buffer
was chosen:
CN CN
CHO H-4--.OH HO+H OH_. NaCN(1.0eq., OH + OH
H O "-oO>
organic solvent-buffer --1Oo>
H O
r. temp.
2
The yields of the cyanohydrins, gluconotrile 2_ and
mannononitrile _3, were measured using HPLC. The total
yield curve producing _2 and 3_ versus reaction time is
shown in figure 2. The initial reaction rate calculated
from the summation yield of _2 and 3_, depended upon the
organic solvent. However, the total yield curves appeared
to level offwithin 5 min. Interestingly, the formation ratio
of_2 to _3 was found to be greatly dependent on the organic
solvent and the pH of the buffer--figure 3.
These results can be divided into three groups. First is
the glucononitrile _2 selective group, in which a mixture
of toluene and alkali buffer was used as the reaction
solvent. In these cases, the formation of_2/3_ increased with
the reaction time and the pH value of the buffer, and
levelled off after 5 min. Second is the non-selective group,
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Figure 2. Time course of total yield of compounds 2_ and 3_ in
organic solvent andpH 10"8 buffer.
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Figure 3. Time course of theformation ratio ofcompound 2_ to _.
in which a mixture of ethyl acetate or diisopropyl ether
and alkali buffer was used. Last is the mannononitrile 3
selective group, in which a mixture of ethanol and alkali
buffer was used. The formation ratio reached the steady
state after 2 min. It seems that the increasing ratio with
time is caused by equilibrium reaction between _2 and _3,
and that the formation ratio of _2/_3 relates to the polarity
of the organic solvent.
In addition, the toluene-buffer condition for preparing _2,
which is the precursor of D-glucose, was examined. Figure
3 shows that the stereoselectivity of the cyanohydrin
formation depends on the pH. Figure 4 shows the yield
curves of _2 when the pH varied from 8"3 to 11"5, but the
reaction rate tended to decrease at high pH such as
pH 11"5. Thus, the optimum pH was found to be 10"8 in
figure 4. To obtain a better understanding of the reaction
mechanism, the dissociation rates of 2 and 3 were
measured. After cyanohydrins 2 and _3 uTere isolated by
silica gel chromatography, each sample (10 gmol) was
added to a mixture of toluene (50 l.tl) and aqueous pH
10"8 buffer (1 M Na2CO3-1 M HC1, 50 t.tl). Each mixture
was stirred at room temperature and analysed by HPLC
Figure 4. Time course ofyield of compound 2_ in toluene-buffer
(H 9"3-1’,).
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Figure 5. Dissociation of compounds 2_ and 3_ in toluene-pH 10.8
buyer.
as shown in figure 5. In both cases, the ratios of_2/_3 varied
with reaction time and after 5 min the ratios stabilized
to 2"1"1. From these results, it is considered that the
stereoselectivity of the cyanohydrin formation is not a
result of cyanide attack on aldehyde _1, but, rather, it is
due to an equilibrium reaction between the products _2
and 3. For the carbon-11 labelling, it was favourable that
the e-quilibrium reaction proceeds rapidly. This method is
practical and not moisture sensitive, so it is possible to
apply to a microsynthesis of aldoses by combining it with
a reductive hydrolysis step. Thus, a one-pot synthesis of
D-glucose and mannose was as shown below:
CHO NaCN Raney Ni HO___O HO__O
H toluene 4M HCI, HCO2"-H OH + OH
-8
pill0.8 Buffer reflux 5rain H > r.temp.,10min OH
D-Glucose D-Mannose
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Figure 6. General view of the remote control room.
to give them in 23"0 and 13"5, respectively. The
one-pot reaction was performed within 15 min. Further-
more, we synthesized )-galactose (28"1o) and D-talose
(11"9) using a similar method from 2,3:4,5-0-isopropyl-
idene-D-lyxose (_4) [12]:
HO HO CHO NaCN Raney N, H;U---O__ OH <O H toluene 4M-HC,, HCO2 ,H .OH + ,HHOOH
r.temp.,lomin OH
D-Galactose D-Talose
Automated apparatus for [1-11C]labelled aldoses
General conceptfor the hardware
The automated apparatus consists of the synthesis system
and the controlling system. The synthesis system, an
auto-manual switch box, and an interface are placed in
a radiation shielded room. As these are removable, it is
convenient for the cold experiment to be performed
elsewhere and to facilitate the maintenance for the
apparatus. The computer and its accessories are placed
in the remote control room. The general appearance is
shown in figures 6 and 7. The synthesis system consists of
a series of units, which have the following functions:
supplying reagents; performing reactions; purifying
[1-11C]labelled aldose; and preparing an injectable
solution of [1-11C]labelled aldose. These operations are
performed by the controlling system and can be performed
manually through the auto-manual switch box, which is
useful in the case of the investigation with the cold
experiment and the maintenance of the apparatus. As the
solenoid valves and other devices of the reagents’ supply
unit and reaction unit were installed on the punched metal
board, it is easy to modify the hardware.
Synthesis system
Reagent and wash solvent supply unit
The reagent supply unit [13] has eight reservoirs (12-19)
in figure 8) for liquid reagents and solvents. Each reagent
and solvent in the reservoirs is under nitrogen atmo-
sphere, and can be transferred to the reaction flasks in
two steps. First, the liquid is allowed to flow from the
reservoir into a volumetric tube (0"5 ml) by nitrogen gas
pressure. When the tube is full and the photosensor (45-52
in figure 8) is activated, the contents of the volumetric
tube are emptied into the reaction flask by nitrogen gas
pressure. The same volume of liquid may be repeatedly
measured and added to the reaction flask. These operations
are performed with three-way solenoid valves, photo-
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sensors and nitrogen gas pressure. In this system, even
moisture or air sensitive liquids can be stored in the
reservoirs and transferred to the reaction flasks. After a
synthetic run, all of the flow lines can be washed and
dried by passing wash solvents which are stored in tanks
(10 and 11 in figure 8), and then nitrogen gas through
them.
Reaction unit
The reaction unit has two reaction flasks (20 and 21 in
figure 8). Reaction flask is used for the hydrocyanation
of a precursor with NaXlCN and flask 2 is used for the
reductive hydrolysis reaction. Both flasks are about 2 ml
in volume and have jackets through which heating/cooling
fluid is circulated with circulator and 2 (24 and 25 in
figure 8). The reaction ,temperature is maintained at the
desired setting by the circulators. The mixing of the
reaction mixture in the flasks are accomplished by
nitrogen gas bubbling. The bubbling rate can be
controlled with two mass flow controllers and 2 (34 and
35 in figure 8). A reaction mixture in flask can be
transferred to flask 2 by using nitrogen gas pressure. The
reaction mixture in flask 2 can be filtered with a glass
filter, which is at the bottom of flask 2, and the filtrate
can be transferred to the purification unit by using
reduced pressure.
Figure 7. Automated synthesis apparatusfor [1-
1C]aldoses. The
apparatus consists of two racks, the synthesis units and I/0 boxes.
Purification unit
The purification unit consists of three devices: an ion
exchange resin column (29 in figure 8), an evaporating
device, and a preparative HPLC device. The filtrate from
V55 V47 V48 V45 V46 V43 V44 V41 V42 V39 V40 V37 V38 V35 V36 V33 V34 V14 V13
Figure 8. Diagram of the synthesis system: V1-V61 solenoid valves; 1 tank of HPLC; 2 degas device; 3 HPLC pump;
4 rotary 6-way valve; 5 HPLC column; 6 column oven; 7 radiation detector; 8 refractive index detector; 9 and 38 drainage
tanks 1 and 2; 10 and 11--washing solvent tank 1 and 2; 12-19 reservoirs 1-8; 20-23 =flasks 1-4; 24-26 circulators
1-3; 27 cold trap; 28 vacuum pump; 29 ion exchange resin column; 30 nitrogen gas line; 31 gas regulator; 32 H CN
gas line; 33 waste gas line; 34 and 35 massflow controller 1 and 2; 36 and 37 magnetic stirrers 1 and 2; 39 sample loop; 40
and 41 roller pumps 1 and 2; 42 bubble trap; 43 pH sensor; 44 level sensor; 45-53 photosensors 1-9; 54-57 =filters
1-4; 58 product output line; 59 pressure sensor.
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flask 2 is desalted with the resin column and transferred
to flask 3 for evaporation. Flask 3 also has a jacket through
which heating fluid is circulated with circulator 3 (26 in
figure 8), and is about 10ml in volume. The mixing
process in flask 3 is performed with the magnetic stirrer
(36 in figure 8). The evaporating process is carried out
with a vacuum device (27 and 28 in figure 8). The
concentrated mixture is then transferred to the auto-
injection device through the bubble trap (42 in figure 8)
with the roller pump (40 in figure 8). An objective
compound is isolated tiom the HPLC column (5 in figure
8) and detected with the refractive index and radiation
detector (7 and 8 in figure 8). The eluate containing the
objective compound is injected into the flask 4 (23 in
figure 8).
Pharmaceutical preparation unit
The pharmaceutical preparation unit has three functions:
adjusting the pH of the radiopharmaceutical solution;
diluting with saline; and filtration with the filter 3 (56 in
figure 8). The aqueous solution of the radiopharmaceutical
in flask 4 is neutralized with a dilute acid or alkali solution
from the reagent’s supply unit. Flask 4 is equipped with
the pH sensor (43 in figure 8), the level sensor (44 in figure
8), and the magnetic stirrer 2 (37 in figure 8). The
radiopharmaceutical solution in flask 4 is filtered with the
membrane filter and roller pump 2 (41 in figure 8). In
the way, the lC-labelled compound is available in
ready-to-use form for the PET study.
Control
Computer and software
The instrumentation is controlled with a personal
computer (PC-9821Ap, NEC), which is linked with the
other computers and LAN (Local Area Network) as
shown in figure 1. An OPTMUX (Opto 22, USA)
interface unit is used. The computer software was
developed by using Hyakuninriki. The program consists
of four processes as follows; hydrocyanation process;
reductive hydrolysis process; purification process; and
pharmaceutical preparation process. A flowchart of these
processes is shown in figure 9.
The hydrocyanation process contains subroutines from
’Add NaCN soln.’ to ’Hydrocyanation in FI’. The
reductive hydrolysis process contains subroutines of’Add
HC1 HCOOH’ and ’Reductive hydrolysis in F2’. The
purification process contains subroutine from ’Desalt’ to
’HPLC’, and the pharmaceutical preparation process
contains subroutines from ’pH adjustment in F4’ to
’Volume adjustment in F4’. The reaction processes are
controlled by a time sequential method, and the injection
process in HPLC is performed by sequential control using
the signal of the photosensor. The processes of pH and
volume adjustments are controlled by a closed-loop
method.
The objective compound is automatically isolated by the
following method. An HPLC chart ofthe reaction mixture
in the case of the preparation for D-glucose is shown in
NO
START
YES
dd NaCN
soln.
soln.
in F1
NO
F1 to F2
]Transfer from
hydrolysis in F2
lAdd
HCI HCOOH
Figure 9. Flowchart of the total operation. F1-4 Flask 1-4.
II
Evaprate l[inF3
a6iustment in F4
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D-Arabinose
D-Glucose
D-Mannose
01 02
tI Time
threshold
Figure 10. HPLC chart of the reaction mixture detected with a
refractive index detector.
figure 10. Until the retention time comes to (tl-
12 min 14 min), all the peaks of the HPLC are ignored.
Collection of the eluate is started when the ratio of peak
variation becomes > (R)1. Collection is stopped when the
ratio of peak variation is < (R)2, and the peak value is less
than the threshold value. This systematic procedure is
highly efficient for isolating the objective compound even
if the HPLC column becomes degraded. A flowchart of
the operation for the ’HPLC’ subroutine is given in figure
11.
Automated synthesis of [1-11C]-D-glucose
The instrumentation is able to produce a series of
[ 1-11C]labelled aldoses; among these, [ 1-11C]-D-glucose
is one of the most popular compounds for PET study.
Therefore, an attempt was made to make an injectable
solution of [ 1-11C]-D-glucose.
Diagnosis check of the appararatus
For radiation protection, a leak test on flasks and 2 and
their tube lines was performed by closing all outlets,
opening them to the nitrogen gas flow line and monitoring
the mass flow controllers. If zero flow could not be
observed, the leak point was searched for and repaired
until zero flow was eatablished.
Settingfor a synthesis of [1-11C]-D-glucose
The HPLC system turned on, then the fluid of the
circulators warmed up to the desired temperature
(circulator "25C, circulator 2" 105C, circulator 3"80C,
START )
Initialized 6-way valve
Roller pump 1 ON
6-way valve 2nd position
V10 and Vll ON
NO
6-way valve- 1st position
Vll -OFF
Ref Idetector auto zero
NO
NO
Figure 11. Flowchart of the operation of the HPLC subroutine.
V12-ONo
N
YES
V12- OFF
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24-26 in figure 8). The cold trap (27 in figure 8) for the
vacuum pump had cooled to -50C. The nitrogen gas
regulator (31 in figure 8) was adjusted to 0-2-0"3 kg/cm2.
The reservoirs (12-19 in figure 8) of the apparatus were
filled as follows: reservoir (a mixture solution ofNaCN
(10 mg, as a carrier) and pH 10"8 buffer (1 M Na2CO3-
M HC1, 1"0 ml)), reservoir 2 (a solution of compound
[46 mg] in toluene, 1"0 ml), reservoir 3 (toluene, 1"0 ml
for washing solvent), reservoir 4 (a mixture of imidazole
(40 mg), 4 M HC1 (0"5 ml) and formic acid (0"5 ml)),
reservoir 5 (distilled water, 10 ml for washing solvent),
reservoir 6 (0"01 M HC1, 10 ml), reservoir 7 (0"01 M
NaHCO3, 10 ml), reservoir 8 (saline, 10 ml). The wash
solvent tanks (10 and 11 in figure 8) were filled as follows:
tank (distilled water, 1000ml), tank 2 (methanol,
1000 ml). Raney nickel (40 mg) was added to reaction
flask 2 (21 in figure 8).
Synthesis ofH11CN
The production ofH11CN was accomplished by an on-line
synthesis according to Iwata’s method [11]. Production
of 11CO2 was accomplished through
14N (p, ) 11C reaction
by proton bombardment 18 MeV, 15 gA) of 14"7 kg/cm}
N2 gas target using a cyclotron-target system (CYPRIS
HM-18, Sumitomo Heavy Industries Co. Ltd). The
11CO2 gas in the target chamber was transferred to 11CO2
gas concentration equipment (AMCT 01, NKK Corp.)
and then the concentrated 11CO gas was transferred to
an HllCN gas generator (AMHC 01, NKK Corp.) using
He gas (flow rate: 100 ml/min) as a carrier gas, and
hydrogenated (flow rate of H2 gas: 10 ml/min) to give
11CH4 gas at 200C in the presence of silica-gel supported
Ru catalyst. The reaction of 11CH4 gas with NH gas
(flow rate: 5 ml/min) at 850C in the presence of Pt
catalyst gave offH11CN gas, which was passed through a
P205 (5"0 g) column to remove excess NHa gas, and then
16"9 GBq (at the end of bombardment) of HllCN gas
was transferred to the automated apparatus for
labelled aldoses.
Hydrocyanation of compound 1_
Nitrogen gas flow rates of the mass flow controller and
2 were set to zero. The outlet of circulator was opened
by switching the valve 49. The outlet of reservoir was
opened by switching the valves 17 and 33. A mixture
solution of NaCN (as a carrier) and pH 10"8 buffer in
reservoir was allowed to flow from reservoir into a
volumetric tube (0"5 ml) by nitrogen gas pressure (nitrogen
gas flow line: 30-31-V13-V14-V34-V33, in figure 8).
When the tube was full and photosensor activated, the
contents ofthe volumetric tube were emptied into reaction
flask by switching the valve 17, 33, and 34 (nitrogen
gas flow line" 30-2 l-V13-V14-V34-V17). When the
volumetric tube was empty and the photosensor was off,
the valve 34 was switched. Trapping ofH11CN gas in flask
was carried out by switching valves 1, 3, and 4 (HllCN
gas flow line: 32-V3-V1-V4-bottom of the flask 1). The
waste gas was exhausted through valve 2 to the waste gas
line. When the introduction of HllCN gas to flask was
finished, valve 3 was switched. To the mixture in flask
was added 0"5 ml of the solution ofcompound 1 in toluene
from reservoir 2 in a similar manner to that of reservoir
using photosensor 2 and the valves 18, 35, and 36. The
mixture in flask was mixed for 8 min by nitrogen gas
bubbling using the mass flow controller (flow rate:
50 ml/min, flow line: 30-34-V3-Vl-V4-bottom of the
flask 1). When the hydrocyanation reaction was finished,
the mixture in flask was transferred to flask 2 by
switching the valves and 4 (nitrogen gas flow line:
30-34-V3-Vl-top of the flask l-V4-top of the flask 2).
The flow rate of mass flow controller was set to zero.
The washing of flask was performed with 0"5 ml of
toluene from reservoir 3 and the washed solvent was
transferred to flask 2 in a similar manner to that mentioned
above.
Reductive hydrolysis of [1-11C]aldononitrile
A solution offormic acid, 4 M HC1, and imidazole (0"5 ml)
from reservoir 4, was added to the mixture of the
cyanohydrins and Raney nickel in flask 2. The outlet of
circulator 2 was opened by switching valve 50. The
mixture in flask 2 was mixed with nitrogen gas from mass
flow controller 2 (nitrogen gas flow line: 30-35-V6-
bottom of the flask 2) at a flow rate of 17"5 ml/min. The
mixture was refluxed for 5 min. The waste gas was
exhausted through valve 7 to the gas waste line. When
the reaction was finished, the gas flow rate of the mass
flow controller 2 was set to zero and valves 49 and 50
were closed to stop circulation.
Purification and pharmaceutical preparation of
[1_11C]-D-glucose
The power switch of the vacuum pump and the magnetic
stirrer under flask 3 were turned on. The outlet of
circulator 3 was opened by switching valve 51. When
valves 6 and 16 were switched, the mixture was filtered
with a glass filter fitted at the bottom of flask 2, the
filtrate was passed through valve 6 and the ion exchange
resin column (IRN-150L, 4"6 mm x 30 cm, Organo Co.
Ltd) to flask 3. Evaporation of the contents of flask 3 was
then performed by switching valve 6. While the evapora-
tion was running, washing solvent (6"5 ml of water,
0"5 ml x 13 portions) from reservoir 5 was added to flask
2 (flow line: 16-V21-V9-V8-top of flask 2) in a
similar manner, and then transferred to flask 3 through
valve 6 and the column in the same manner. When the
evaporation was finished, the outlet of circulator 3 was
closed by switching valve 51, and in order to break the
vacuum line valves 10, 16, amd 56 were switched and the
power switch of the vacuum pump was turned off. The
residue in flask 3 was dissolved in 0"5 ml water delivered
from reservoir 5 in a similar manner (flow line: 16-V21-
V9-V11-flask 3). After dissolving the residue, magnetic
stirring was stopped, the aqueous solution was injected
to the HPLC system as follows: valves 10 and 11 were
switched, the aqueous solution containing air bubbles was
delivered to the bubble trap via valve 58 with the roller
pump 1, the debubbled solution in the bubble trap was
sent to the sample loop via photosensor 9 and the rotary
six-way valve, when the end of the solution line was
detected by the photosensor 9, the rotary six-way valve
was switched and the solution in the sample loop was
loaded to the HPLC column.
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The HPLC separation conditions were as follows: column:
Bio-Rad Aminex HPX-87P (7"8 mm x 30 cm, 9 gm),
mobile phase: water, flow rate: 0"6 ml/min, temperature:
85C, retention time of D-glucose: 13"4 min. When the
eluate containing [1-11C]-D-glucose was detected with
the refractive index detector (RI-71, Shodex Co. Ltd) and
the radiation detector (TCS-R81-3454, Aloka Co. Ltd),
valve 12 was switched and the eluate was transferred to
flask 4. The magnetic stirrer was switched on and the pH
value of the eluate in flask 4 was measured with the pH
sensor. As the pH value was in the range from 6"5 to 7"5,
the addition of the acid in reservoir 6 or the alkali in
reservoir 7 was not performed. Thus the solution was
diluted with the saline in reservoir 8. The saline was added
to flask 4 repeatedly until the level sensor was activated
which was set to a volume of 10 ml. Finally, the injectable
solution of [1-1C]-D-glucose was obtained by filtration
with roller pump 2 and the membrane filter 3. The total
synthesis time was 49 min. The product was analysed by
remote monitoring and operatingand the analysis data
were found to be as follows: chemical yield 2"0 from
NaCN, radiochemical yield 1"3 from HICN, radio-
activity of [1-C]-D-glucose 47 MBq, chemical purity:
>98, radiochemical purity >95.
Conclusion
A rapid synthesis of aldononitrile compounds using an
equilibrium reaction has been developed and the results
show the feasibility of synthesis of either 2R or 2S aldoses
under simple reaction conditions. On the basis of these
investigations, an automated synthesis instrument was
built which is capable of producing a wide variety of
[1-lC]labelled aldoses in a ready-to-inject form. As the
instrumentation consists of a series of units and can be
improved, it may be appropriate for laboratory use.
A preliminary, hot experiment using the instrumentation
was successful and an injectable solution of [1-xC]
D-glucose was obtained automatically. The difference in
yield between the cold experiment and the hot experiment
could be caused by the absorption in the flasks and
columns. The authors are now working on the optimization
of the operation conditions and the synthesis of the other
labelled aldoses.
Experimental
Materials and reagents
Raney nickel was purchased from Nakarai Tesque, Inc.
The other reagents and organic solvents were purchased
from Wako Pure Chemical Industries, Ltd. All solvents
were distilled and filtered with a membrane filter before
use.
Analysis
The melting-point of compound _2 is measured with a
Yanagimoto micro melting-point apparatus without
correction. NMR were recorded using Varian Instru-
ments’ GEM-300 spectrometer. Chemical shifts () were
recorded in ppm from tetramethylsilane (in CDC13 and
C6D6) as an internal standard. HPLC analysis was
performed with a Shimadzu LC-9A pump, a Shodex
refractive index detector RISE-61, an Aloka positron
detector TCS-R81-3454 and three separate analytic
systems were used:
(1) Analysis of aldononitrile _2 and 3_"
Column: Waters radialpak C-18 (8 mm x 10 cm,
5 lam).
Mobile phase: acetonitrile" 0"003 M KH2PO4 2" 3.
Flow rate: 1"5 ml/min.
Temperature: 25C.
Retention time" compound 2_ (12"38 min), compound
3_ (11"47 min).
(2) Analysis of aldoses"
Column" Bio-Rad Aminex HPX-87P (7"8mm x
30 cm, 9 gm).
Mobile phase" water.
Flow rate" 0"6 ml/min.
Temperature: 85C.
Retention time: D-glucose (13"40min), D-mannose
(17"20 min), D-arabinose (16"30 min), D-galactose
(14"53 min); D-talose (31"19 min), D-lyxose
17"38 min).
(3) Analysis of aldoses:
Column: Shodex Ionpak KS-801 (8 mm x 30 cm).
Mobile phase: water.
Flow rate: 1"0 ml/min.
Temperature: 80C.
Rentention time" D-glucose (8"20min), D-mannose
(8"70 min).
D-Arabinose (9"30 min).
The analysis of [1-aXC]-D-glucose was performed by
remote control. The HPLC analysis was accomplished
using a Shimadzu LC-9A pump, a Shodex refractive index
detector RISE-61, an Aloka positron detector TCS-
R81-3454, a handmade auto sampler, and a Shimadzu
C-R4AX two-channel data processor. The radioactivity
of the product was measured with a CAPINTEC
CRC-712 dose calibrator.
Cold synthesis of aldose derivatives
Preparation of 3,4 5,6-di-O-isopropylidene-z)-glucononitrile (2_)
and 3,4 5,6-di-O-isopropylidene-z-rnannononitrile
(_)
To a solution ofcompound 1 [9] (450 mg, 1"95 mmol) in
toluene (10 ml) was added a mixture of sodium cyanide
(96mg, 1"95mmol) and pH 10"8 buffer (10ml, M
Na2CO3-1 M HC1) at 25C. The mixture was stirred at
the same temperature for 10 min. The organic layer was
separated, dried with anhydrous sodium sulphate, and
evaporated in vacuo to give colourless oil. The residue
was purified by silica-gel column chromatography (Wako,
Wakogel C-200, 25 g, dichloromethane’diethyl ether---
40" 1) to give compound _2 (218 mg, 43"5 as crystals)
and compound 3_ (118 mg, 23"5 as a colourless oil),
respectively. Compound 2_" melting point 82-84C;
H NMR (C6D6) 6 1"133 (3H, s, CH3) 1.286 (3H, s,
CH3), 1.396 (3H, s, CH3), 1.419 (3H, s, CH3), 3.672 (1U,
m, J= 6"0 and 9"1 Hz, H-5), 3"771 (1H, dd, J= 3"0
and 9"1 Hz, H-3), 3"878 (1H, dd, J 6"0 and 9"1 Hz,
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H-6a), 3-982 (1H, q, J= 9.1 Hz, H-6b), 4.178 (1H, t,
J 9.1 Hz, H-a), 4.461 (1H, d, J 11.3 Hz, 1-OH),
4.633 (1H, dd, J 3.0 and 11"3 Hz, H-2); 13C NMR
(C6D6) 6 24"772 (CH3) 26"316 (CH3) 26"523 (CH3)
26"920 (CH3) 61"897 (C-2), 67"684 (C-6), 75"939 (C-5),
78"789 (c-a), 80.244 (C-3), 110.766 (isopropylidene,
C), 118"445 (C-l). Compound _3" XH NMR (CDC13)
6 1"355 (3H, s, CH3) 1"431 (3H, s, CH3) 1"441 (3H,
s, CH3) 1"471 (3H, s, CH3) 3"763 (1H, dd, J 7"9 and
8"5 Hz, H-4), 4"010 (1H, dd, J 4"3 and 8"4 Hz, H-6a),
4"070 (1H, m, J 4"3, 5"7, and 8"5 Hz, H-5), 4"120 (1H,
dd, J 5" and 7"9 Hz, H-3), 4" 192 (1 H, dd, J 5"7 and
8.4 Hz, H-6b), 4-588 (1H, d,J= 5.1Hz, H-2); 3C NMR
(C6D6) 6 25.043 (CH3) 26.208 (CH3), 26.679 (CH3),
26.942 (CH3) 63.516 (C-2), 67.799 (C-6), 76.271 (C-5),
79"292 (C-4), 80.577 (C-3), 109.98 (isopropylidene, C),
111-83 (isopropylidene, C), 117"496 (C-l).
One-pot synthesis of D-glucose and D-mannose
A mixture of sodium cyanide (5 mg, 0"1 mmol) and pH
10"8 buffer (0"5 ml, M Na2CO3-1 M HC1) at 25C was
added to a solution of compound 1 (23 mg, 0"1 mmol) in
toluene (0"5 ml). The mixture was stirred at the same
temperature for 10 min. To the mixture was added a
mixture of Raney nickel (40 mg), formic acid (0"25 ml),
4 M HCl (0"25 ml), and imidazole (20 mg). The mixture
was heated at 105C for 5 min, and then filtered. The
filtrate was evaporated in vacuo to give a residue. The
purification was performed by the HPLC system to give
D-glucose (4"1 mg, 23"0o) and D-mannose (2"4mg,
13"5), respectively. These operations were carried out
using the mock-up apparatus.
One-pot synthesis of D-galactose and D-talose
These compounds were prepared in a similar manner
to that of D-glucose and D-mannose. The starting
material, 2,3:4,5-di-0-isopropylidene-D-lyxose (_4) can
be derived by Lee’s method [12]. In this way, D-galactose
and D-talose were obtained in yields of 28"1 and 11"9,
respectively.
Acknowledgements
The authors wish to thank Dr Teruo Omae, President of
the National Cardiovascular Center, for supporting this
work, and to Drs Masadzumi Watanabe, Tohru Sugawara,
and D. G. Cork at Takeda Chemical Industries Ltd for
useful discussions.
References
1. WOLF, A. P. and FLOWER, J. S., in Positron Emission Tomography,
Reivich, M. and Alavi, A. (Eds) (Alan R. Liss Inc., New York,
1985), 63.
2. RAmnLE, M. E., LaRSON, K. B., PHELPS, M. E., GRUUU, JR., R. L.
and TER-PooossIAN, M. M., American Journal of Physiology, 228
(1975), 1936.
3. BERGSTROM, M., COLLINS, P. and EHRIN, E., Computer Assisted
Tomography, 7 (1983), 1062.
4. SmJE, C.-Y. and WOLF, A. P., Journal of Labelled Compounds and
Radiopharmaceuticals, 22 (1985), 171.
5. SGHOEPS, K.-O., LNOSTRM, B., STONE-LEANDER, S. and HALLDIN,
C., Applied Radiation and Isotopes, 42 (1991), 877.
6. DENCE, C. S. and WELCH, M. J., Journal of Labelled Compounds and
Radiopharmaceuticals, 32 (1993), 574.
7. LINgS, J. M., COURTER, J. H. and KROHN, K. A., Journal ofNuclear
Medicine, 30 (1989), 928.
8. STONE-ELANDER, S., HALLDIN, C., L.NGSTR6M, B., BLOMQVIST, G.
and WIDEN, L., Applied Radiation and Isotopes, 43 (1992), 721.
9. ZIMMER, H., WITTENBURG, E. and REMBARZ, G., Chemische Berichte,
92 (1959), 721.
10. NISHIMURA, S. and HAYASHI, N., Chemistry Letters (Japan) (1991),
1815.
11. IWATA, R., IDo, T., TAKAHASHI, H. and IIDA, S., Applied Radiation
and Isotopes, 38 (1987), 97.
12. LEE, A. W. M., MARTIN, V. S., MASAMUNE, S., SHARPLESS, K. B.
and WALKER, F. J., Jotrnal ofAmerican Chemical Society, 104 (1982),
3515.
13. HAYASm, N., SUOAWARA, T., SHINTANI, g. and KATO, S., Journal
of Automatic Chemistry, 11 (1989), 212.
204